A New Conversational AI SaaS Solution for Cancer Clinical Trial Matching

New solution named ‘Tara’ provides embeddable and scalable patient engagement platform for hospitals, health systems and CROs.

Tara Expands Belong’s Proven Clinical Matching Services to Thousands More Patients.

Belong.Life, a leading global provider of high-engagement patient communities and care platforms, today announced the launch of Tara, a SaaS-based conversational AI cancer clinical trial matching platform for health providers and contract research organizations (CROs). The solution is designed to accelerate the process of matching patients with eligible clinical trials, enabling increased recruitment at significantly lower costs. Tara is the second product in Belong’s AI Health Mentor suite of solutions, following the launch of Dave, the world’s first conversational AI oncology mentor.

Continue Reading >

More Articles

ASCO 2024: Oncologists support Belong.Life’s AI cancer mentor Dave

Belong.Life asked a group of senior oncologists to review the responses provided to patients and…

Lessons on AI Support for Cancer Care

The integration of artificial intelligence (AI) in oncology care has allowed for unprecedented levels of…

“Dave AI”: a Game-Changer app for cancer patients

Eliran Malki and Belong.Life Help People Navigate Cancer Care with an On-Demand AI Coach with…
Skip to content